1. Home
  2. BEEM vs HBIO Comparison

BEEM vs HBIO Comparison

Compare BEEM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.41

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$8.07

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
HBIO
Founded
2006
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
26.5M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
BEEM
HBIO
Price
$1.41
$8.07
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$3.50
$18.00
AVG Volume (30 Days)
1.5M
21.2K
Earning Date
04-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
40.77
N/A
EPS
N/A
N/A
Revenue
$28,236,000.00
$116,176,000.00
Revenue This Year
$40.48
$4.77
Revenue Next Year
$32.17
$8.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$0.38
52 Week High
$4.04
$8.40

Technical Indicators

Market Signals
Indicator
BEEM
HBIO
Relative Strength Index (RSI) 54.34 70.00
Support Level $1.38 $5.91
Resistance Level $1.42 N/A
Average True Range (ATR) 0.13 0.31
MACD -0.01 0.01
Stochastic Oscillator 23.91 75.57

Price Performance

Historical Comparison
BEEM
HBIO

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: